Europska Unija - engleski - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner, milbemycin oxime - endectocides, antiparasitic products, insecticides and repellents, milbemycin oxime, combinations - dogs - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum), thelaziosis (adult thelazia callipaeda) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks. treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis). treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis). prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration. prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.prevention of establishment of thelaziosis (adult thelazia callipaeda eyeworm infection) with monthly administration.

Europska Unija - engleski - EMA (European Medicines Agency)

elanco gmbh - pyriprole - ectoparasiticides for topical use, incl. insecticides - dogs - treatment and prevention of flea infestation (ctenocephalides canis and c. felis) in dogs. efficacy against new infestations with fleas persists for a minimum of 4 weeks.treatment and prevention of tick infestation (ixodes ricinus, rhipicephalus sanguineus, ixodes scapularis, dermacentor reticulatus, dermacentor variabilis, amblyomma americanum) in dogs. efficacy against ticks persists for 4 weeks.

Europska Unija - engleski - EMA (European Medicines Agency)

pfizer limited  - metaflumizone, amitraz - ectoparasiticides for topical use, incl. insecticides - dogs - for the treatment and prevention of infestations by fleas (ctenocephalides canis and c. felis), and ticks (ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus, dermacentor reticulatus and dermacentor variabilis), and treatment of demodicosis (caused by demodex spp.) and lice (trichodectes canis) in dogs.the veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (fad).

Europska Unija - engleski - EMA (European Medicines Agency)

zoetis belgium sa - sarolaner - ectoparasiticides for systemic use - dogs - for the treatment of tick infestations (dermacentor reticulatus, ixodes hexagonus, ixodes ricinus and rhipicephalus sanguineus). the veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks.for the treatment of flea infestations (ctenocephalides felis and ctenocephalides canis). the veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks. the veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of sarcoptic mange (sarcoptes scabiei).for the treatment of ear mite infestations (otodectes cynotis).for the treatment of demodicosis (demodex canis).fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.

Europska Unija - engleski - EMA (European Medicines Agency)

ceva sante animale - dinotefuran, pyriproxyfen, permethrin - permethrin, combinations - dogs - treatment and prevention of flea infestation (ctenocephalides felis and ctenocephalides canis).treatment and prevention of tick infestation (rhipicephalus sanguineus, dermacentor reticulatus, ixodes ricinus).prevention of biting from sand flies (phlebotomus perniciosus), mosquitoes (culex pipiens, aedes aegypti) and stable flies (stomoxys calcitrans).treatment of mosquito (aedes aegypti) and stable fly (stomoxys calcitrans) infestation.

Europska Unija - engleski - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner - ectoparasiticides for systemic use - dogs - treatment of flea (ctenocephalides felis and c. canis) infestations. the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad). treatment of tick (dermacentor reticulatus, ixodes ricinus, rhipicephalus sanguineus) infestations. treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).,

Europska Unija - engleski - EMA (European Medicines Agency)

zoetis belgium s.a. - moxidectin, sarolaner, pyrantel embonate - antiparasitics - dogs - for dogs with, or at risk from, mixed external and internal parasitic infestations. the veterinary medicinal product is exclusively indicated when use against ticks or fleas and gastrointestinal nematodes is indicated at the same time. the veterinary medicinal product also provides concurrent efficacy for the prevention of heartworm disease and angiostrongylosis.ectoparasitesfor the treatment of tick infestations. the veterinary medicinal product has immediate and persistent tick killing activity for 5 weeks against ixodes hexagonus, ixodes ricinus and rhipicephalus sanguineus and for 4 weeks against dermacentor reticulatus;for the treatment of flea infestations (ctenocephalides felis and ctenocephalides canis). the veterinary medicinal product has immediate and persistent flea killing activity against new infestations for 5 weeks;the veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).gastrointestinal nematodesfor the treatment of gastrointestinal roundworm and hookworm infections:toxocara canis immature adults (l5) and adults;ancylostoma caninum l4 larvae, immature adults (l5) and adults;toxascaris leonina adults;uncinaria stenocephala adults.other nematodesfor the prevention of heartworm disease (dirofilaria immitis);for the prevention of angiostrongylosis by reducing the level of infection with immature adult (l5) stages of angiostrongylus vasorum.

Izrael - engleski - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 1000 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Izrael - engleski - Ministry of Health

intervet ( israel) ltd - fluralaner - spot-on solution - fluralaner 280 mg / 1 ml - for the treatment of tick and flea infestations in dogs.this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and persistent flea (ctenocephalides felis and ctenocephalides canis) killing activity for 12 weeks, and- immediate and persistent tick (ixodes ricinus, rhipicephalus sanguineus and dermacentor reticulatus) killing activity for 12 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.

Izrael - engleski - Ministry of Health

intervet ( israel) ltd - fluralaner - chewable tablets - fluralaner 112.5 mg - dogs: for the treatment of tick and flea infestations in dogs. this veterinary medicinal product is a systemic insecticide and acaricide that provides:- immediate and presistent flea (ctenocephalides felis) killing activity for 12 weeks,- immediate and persistent tick killing activity for 12 weeks for ixodes ricinus, dermacentor reticulatus and d. variabilis,- immediate and presistent tick killing activity for 8 weeks for rhipicephalus sanguineus.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. the onset of effect is within 8 hours of attachment for fleas (c. felis) and 12 hours of attachment for ticks (i. ricinus). the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).for the treatment of demodicosis caused by demodex canis.for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.